{"title":"日本深静脉血栓诊断与治疗趋势的回顾性观察研究:日本静脉研究XXVI。","authors":"Michihisa Umetsu, Takashi Yamaki, Tomohiro Ogawa, Toshiya Nishibe, Yasushi Shiraishi, Norikazu Yamada, Takashi Matsumoto, Tadashi Nomura, Atsushi Tabuchi, Yugo Yamashita, Hiroko Nemoto, Shinichi Hiromatsu, Makoto Mo","doi":"10.3400/avd.oa.25-00061","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objectives:</b> The introduction of direct oral anticoagulants (DOACs) has significantly changed the management of deep vein thrombosis (DVT) in Japan. This study aimed to elucidate recent trend0s in the diagnosis and management of DVT following this shift. <b>Methods:</b> This retrospective observational study involved 154 patients with acute and subacute DVT, and 96 patients with chronic or unknown-onset DVT, diagnosed between October 1 and 31, 2020, across 29 institutions affiliated with the Japanese Society of Phlebology. Data included patient demographics, diagnostic modalities, thrombus location, treatments, and clinical outcomes. <b>Results:</b> The mean age was 70.0 years, and 57.8% of patients were female. Duplex ultrasonography was the predominant diagnostic modality (96.1%). DOACs were prescribed in 64.9% of patients, replacing warfarin and heparin. Compression therapy was used in 41.6% of patients. Soleal vein thrombosis was significantly more common in isolated distal DVT (right: 50.6% vs. 30.0%, p = 0.0082; left: 66.3% vs. 35.2%, p = 0.0001). Major bleeding occurred in 3.2% of patients. Post-thrombotic syndrome was observed in 0.6% of patients with acute/subacute DVT and 12.0% of those with chronic DVT patients. <b>Conclusions:</b> Since the introduction of DOACs, DVT management in Japan has evolved considerably. Periodic multicenter surveys would be beneficial for evaluating long-term outcomes, treatment safety, and evolving clinical practices.</p>","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"18 1","pages":""},"PeriodicalIF":0.6000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12368433/pdf/","citationCount":"0","resultStr":"{\"title\":\"Retrospective Observational Study on Diagnosis and Treatment Trends of DVT in Japan: Japanese Vein Study XXVI.\",\"authors\":\"Michihisa Umetsu, Takashi Yamaki, Tomohiro Ogawa, Toshiya Nishibe, Yasushi Shiraishi, Norikazu Yamada, Takashi Matsumoto, Tadashi Nomura, Atsushi Tabuchi, Yugo Yamashita, Hiroko Nemoto, Shinichi Hiromatsu, Makoto Mo\",\"doi\":\"10.3400/avd.oa.25-00061\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Objectives:</b> The introduction of direct oral anticoagulants (DOACs) has significantly changed the management of deep vein thrombosis (DVT) in Japan. This study aimed to elucidate recent trend0s in the diagnosis and management of DVT following this shift. <b>Methods:</b> This retrospective observational study involved 154 patients with acute and subacute DVT, and 96 patients with chronic or unknown-onset DVT, diagnosed between October 1 and 31, 2020, across 29 institutions affiliated with the Japanese Society of Phlebology. Data included patient demographics, diagnostic modalities, thrombus location, treatments, and clinical outcomes. <b>Results:</b> The mean age was 70.0 years, and 57.8% of patients were female. Duplex ultrasonography was the predominant diagnostic modality (96.1%). DOACs were prescribed in 64.9% of patients, replacing warfarin and heparin. Compression therapy was used in 41.6% of patients. Soleal vein thrombosis was significantly more common in isolated distal DVT (right: 50.6% vs. 30.0%, p = 0.0082; left: 66.3% vs. 35.2%, p = 0.0001). Major bleeding occurred in 3.2% of patients. Post-thrombotic syndrome was observed in 0.6% of patients with acute/subacute DVT and 12.0% of those with chronic DVT patients. <b>Conclusions:</b> Since the introduction of DOACs, DVT management in Japan has evolved considerably. Periodic multicenter surveys would be beneficial for evaluating long-term outcomes, treatment safety, and evolving clinical practices.</p>\",\"PeriodicalId\":7995,\"journal\":{\"name\":\"Annals of vascular diseases\",\"volume\":\"18 1\",\"pages\":\"\"},\"PeriodicalIF\":0.6000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12368433/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of vascular diseases\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3400/avd.oa.25-00061\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/8/14 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of vascular diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3400/avd.oa.25-00061","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/14 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0
摘要
目的:在日本,直接口服抗凝剂(DOACs)的引入显著改变了深静脉血栓(DVT)的治疗。本研究旨在阐明随着这一转变,深静脉血栓的诊断和治疗的最新趋势。方法:这项回顾性观察性研究纳入了154例急性和亚急性DVT患者,以及96例慢性或不明原因DVT患者,这些患者于2020年10月1日至31日期间被诊断出患有DVT,来自日本静脉学会附属的29家机构。数据包括患者人口统计、诊断方式、血栓位置、治疗和临床结果。结果:平均年龄70.0岁,女性占57.8%。超声检查为主要诊断方式(96.1%)。64.9%的患者使用doac替代华法林和肝素。41.6%的患者采用压迫治疗。孤立性远端DVT中单梢静脉血栓形成更为常见(右:50.6% vs. 30.0%, p = 0.0082;左:66.3% vs. 35.2%, p = 0.0001)。3.2%的患者发生大出血。0.6%的急性/亚急性DVT患者和12.0%的慢性DVT患者出现血栓形成后综合征。结论:自doac引入以来,日本的DVT管理有了很大的发展。定期的多中心调查将有助于评估长期结果、治疗安全性和不断发展的临床实践。
Retrospective Observational Study on Diagnosis and Treatment Trends of DVT in Japan: Japanese Vein Study XXVI.
Objectives: The introduction of direct oral anticoagulants (DOACs) has significantly changed the management of deep vein thrombosis (DVT) in Japan. This study aimed to elucidate recent trend0s in the diagnosis and management of DVT following this shift. Methods: This retrospective observational study involved 154 patients with acute and subacute DVT, and 96 patients with chronic or unknown-onset DVT, diagnosed between October 1 and 31, 2020, across 29 institutions affiliated with the Japanese Society of Phlebology. Data included patient demographics, diagnostic modalities, thrombus location, treatments, and clinical outcomes. Results: The mean age was 70.0 years, and 57.8% of patients were female. Duplex ultrasonography was the predominant diagnostic modality (96.1%). DOACs were prescribed in 64.9% of patients, replacing warfarin and heparin. Compression therapy was used in 41.6% of patients. Soleal vein thrombosis was significantly more common in isolated distal DVT (right: 50.6% vs. 30.0%, p = 0.0082; left: 66.3% vs. 35.2%, p = 0.0001). Major bleeding occurred in 3.2% of patients. Post-thrombotic syndrome was observed in 0.6% of patients with acute/subacute DVT and 12.0% of those with chronic DVT patients. Conclusions: Since the introduction of DOACs, DVT management in Japan has evolved considerably. Periodic multicenter surveys would be beneficial for evaluating long-term outcomes, treatment safety, and evolving clinical practices.